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Abstract
Traditionally seen as a sudden, brutal event with short-term impairment, traumatic brain injury (TBI) may cause
persistent, sometimes life-long, consequences. While mortality after TBI has been reduced, a high proportion of
severe TBI survivors require prolonged rehabilitation and may suffer long-term physical, cognitive, and psychological
disorders. Additionally, chronic consequences have been identified not only after severe TBI but also in a proportion of
cases previously classified as moderate or mild. This burden affects the daily life of survivors and their families; it also
has relevant social and economic costs.
Outcome evaluation is difficult for several reasons: co-existing extra-cranial injuries (spinal cord damage, for instance)
may affect independence and quality of life outside the pure TBI effects; scales may not capture subtle, but important,
changes; co-operation from patients may be impossible in the most severe cases. Several instruments have been
developed for capturing specific aspects, from generic health status to specific cognitive functions. Even simple
instruments, however, have demonstrated variable inter-rater agreement.
The possible links between structural traumatic brain damage and functional impairment have been explored both
experimentally and in the clinical setting with advanced neuro-imaging techniques. We briefly report on some
fundamental findings, which may also offer potential targets for future therapies.
Better understanding of damage mechanisms and new approaches to neuroprotection-restoration may offer better
outcomes for the millions of survivors of TBI.
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Background
Traumatic brain injury (TBI) affects millions of people
worldwide. Its incidence (new cases per year), including
the whole range of severity from minor to devastating
injuries, varies in different countries, from 60 cases per
100,000 inhabitants up to figures 12 times higher [1],
reflecting local variations and, most likely, different
inclusion criteria and methodologies. Epidemiology is
changing, with more TBI due to increased motorization
in several developing countries, while ageing of the
population in the Western hemisphere increases the
incidence of injuries due to falls in the elderly [2].
Mortality in severe TBI was higher than 50 % (up to
80 % in cases older than 60 years) in an old series [3].
Results have improved over the past decades and mor-
tality has been reduced to 30–40 % [4]. The increased
number of survivors, however, includes both successful
cases who are back to an enjoyable life and cases with
persistent disabilities (Table 1).
A proportion of severe TBI survivors, after prolonged
hospital care, require long rehabilitation and may have
long-term physical, cognitive, and psychological disor-
ders. Such disorders may disrupt previous relationships
and preclude return to work, with severe economic and
social impacts. The global burden is such that TBI survi-
vors have a lower life expectancy than the general popu-
lation [4].
The weight of chronic consequences relative to med-
ical care and rehabilitation costs has been estimated by
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calculating lifetime costs per case of severe TBI in the
USA: 80 % of the estimated total cost (approximately
USD 400,000) was attributable to disability and lost
productivity [4].
The fact that severe brain damage is linked to harsh,
long-lasting consequences is not unexpected. New data
suggest, however, that disability may be common also
after hospital admission for (apparently) mild head injur-
ies. Accurate follow-up of 549 cases in Scotland esti-
mated moderate or severe disability after mild TBI in
42–52 % of cases. A Canadian systematic review on the
consequences of mild TBI, however, gives much lower
figures [5]. Existing data are, therefore, insufficient to
draw conclusions.
Figures on the prevalence of people living with the
consequences of TBI are even less well documented; it
has been estimated, however, that several million people
(approximately five million in the USA and seven million
in Europe) were living with TBI-related disability 10 years
ago [6, 7].
No data are available for countries such as India
and China, where TBI incidence is increasing due to
motorization.
The consequences of injury may be attenuated by high
quality care in the emergency setting, in the ICU, and
over the whole rehabilitation process; family and social
support also plays an important role. Economic and so-
cial disparities, with unequal access to resources and
treatment, may, therefore, deeply influence outcome.
This review is based on a comprehensive literature
review which is detailed in Fig. 1. The selection process
was conducted by the authors aiming at a narrative
review, not a systematic literature review.
Biology of traumatic brain injury
Brain trauma is an acute biomechanical event character-
ized by multiple pathophysiological processes that de-
velop over time in a continuum (Fig. 2). TBI survivors
are affected by a “polypathology” whose main features
are white matter degradation, neuronal loss, protein mis-
folding, and persistent neuroinflammation. Alterations of
neurotransmitter systems have also been described [8].
White matter degradation
Neuronal circuits and functions depend on white matter
integrity [9]. Seminal neuropathological studies by
Adams and colleagues have documented the distribution
of axonal pathology in a large series of TBI cases and
have introduced the concept of “diffuse axonal injury”
[10, 11]. Shear-tensile forces due to trauma may cause a
disruption of the axonal cytoskeleton and impair axonal
transport. Additional neurochemical changes, such as
intracellular calcium overload, may further damage the
axons. Thus, TBI affects structural brain networks pro-
gressively, from focal axon alteration to delayed axonal
disconnection [12, 13].
The functional and structural connectivity in patients
can now be investigated by resting-state functional MRI
and advanced diffusion imaging (Fig. 3), respectively,
documenting axonal damage over a wide range of injury
severities [8, 14, 15].
Studies indicate that even apparently intact axons with
disrupted physiology may contribute greatly to clinical
dysfunction in mild TBI. White matter abnormalities on
advanced neuroimaging studies are evident in many
patients in whom CT scans are normal and are strong pre-
dictors of long-term consequences [2, 9, 16, 17]. Serum
markers of axonal injury are emerging (i.e., “SNTF”, a pro-
teolytic fragment of alpha-II spectrin) that may assist in
monitoring of neuropathology progression [18].
Protein misfolding
TBI is a risk factor for delayed neurodegeneration and
dementia, including Alzheimer’s disease and chronic
traumatic encephalopathy [19, 20]. Several mechanisms
may be implicated, including axonal injury, neuronal
Table 1 Outcome at 6 months (percent data) from major pharmacological trials and consecutive series
Publication year Patient number Death Vegetative state Severe disability Moderate disability Good recovery
Neuroprotective trials: placebo groups
Tirilazad [82] 1998 459 28 4 13 17 38
Metilprednisolone [48] 2005 4819 22 Included in the
mortality rate
14 17 46
Progesteron [83] 2014 588 22 Not reported 27 19 31
Consecutive series
EBIC [84] 1999 796 31 2 16 20 31
NeuroLink [85] 2012 1273 33 3 14 17 33
UK RAIN study [86] 2013 2620 26 Not reported 33 22 19
Results at 6 months shown in this table are not corrected for severity. Better results in the neuroprotective trials may depend on the exclusion of the most severe
cases, who are not amenable to randomization but are, on the contrary, included in consecutive series. The Metilprednisolone study included severe and
moderate TBI
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loss, persistent inflammation, and prolonged blood–
brain barrier disruption [21–24]. However, the neuro-
pathological link that is receiving most attention is
the accumulation of amyloid-β peptides and aberrant
microtubule-associated protein tau, two common fea-
tures in Alzheimer disease. Tau pathology has been
shown to occur in rodent models of TBI within
2 weeks of injury [25–27]. Recent evidence indicates
that a focal brain trauma in mice leads to persistent
tau pathology which disrupts axonal microtubule net-
works, propagates to remote regions in the brain, and
is associated with brain dysfunction [28].
Persistent inflammatory response
The inflammatory response in TBI includes local cere-
bral production of cytokines and chemokines, endothe-
lial activation, microglial activation, and migration of
systemic neutrophils, lymphocytes, and monocytes into
the injured brain. In experimental TBI, microglial cells
readily activate [29] and remain chronically activated for
at least one year after injury [30], spreading form the site
of injury to remote regions in the brain. Clinical data
from TBI brain autopsies and from positron emission
tomography of TBI patients identify chronic microglia
activation up to several years after injury and document
a close association between neuropathology and inflam-
mation in space and time [31, 32]. Experimental studies
show that aspecific suppression of the inflammatory
response may protect the injured tissue early on but
harm the brain at chronic stages [33], suggesting that
therapeutic strategies should aim at modulation, rather
than inhibition, of the inflammatory response.
Neurorestorative processes
In addition to toxic processes, TBI also induces neuror-
estorative events that include neurogenesis, gliogenesis,
Fig. 1 Flow diagram of literature search
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angiogenesis, synaptic plasticity, and axonal sprouting.
These processes are stimulated by endogenous growth-
related factors and may persist for weeks to months,
contributing to recovery after TBI.
The adult brain retains neurogenic zones with neural
stem cells that can differentiate into functional neurons
[34, 35]. Several laboratories have reported an increased
proliferative response in the hippocampus beginning as
early as 2 days post-injury [36], with a peak in the first
weeks after injury [37]. The proliferation in the dentate
gyrus is age-dependent, with the juvenile brain showing a
greater potential [36]. Newly generated neuroblasts [38]
have been shown to migrate toward the site of injury [39]
and to participate in cognitive recovery [40, 41]. Next to
neurogenesis, axonal sprouting and synaptogenesis from
surviving neurons may play a role in spontaneous motor
recovery after TBI [42, 43]. However, all these spontan-
eous brain restorative processes are short-lived [44–46].
Outcome assessment
Outcome assessment after TBI is complex and the spe-
cific consequences due to brain damage are sometimes
difficult to identify. Brain trauma, especially in the case
of road traffic accidents, is often associated with extra-
cranial injuries. These injuries may themselves cause dis-
abilities, sometimes to an overwhelming extent, as in
case of concomitant spinal cord damage. Facial injuries,
ocular damage, limb lesions or amputations, pelvic frac-
tures, etc. are further examples of associated injuries po-
tentially affecting quality of life (QoL) independent of, or
in association with, brain damage.
Accordingly, pre-existing diseases may confuse the as-
sessment: if TBI affects a person with a history of sub-
stance abuse or in the context of severe psychiatric
disorders, the dissection of the pure effect of head injury
becomes arduous or impossible.
The Glasgow Outcome Scale (GOS), a simple, five
point scale, was designed in 1975 specifically for asses-
sing outcome after TBI [47]. It became extremely popu-
lar as a simple tool to assess overall patient disability
without detailed neurological and psychological evalua-
tions, usually through a short interview. Its apparent
simplicity was extremely attractive and the scale has
been used in major clinical trials, such as CRASH [48],
where approximately 10,000 cases were scored at
6 months after TBI. Limitations, however, were quickly
identified: the broad categories couldn’t capture subtle
changes, physical disabilities were better characterized
than cognitive or behavioral problems, and the inter-
rater agreement could vary widely [49].
Two major improvements have been subsequently in-
troduced: an extended GOS scale, based on eight cat-
egories, and a structured interview for guiding the
examiners toward a final accurate score [50]. Emphasis
was put on assessing changes from the pre-injury status,
accounting for pre-existing problems, and in assessing
both mental and physical disabilities. The structured
interview also suggested a simple exploration of social
interactions, leisure attitudes, etc.
Despite the simplicity of the GOS and the guidance of-
fered by the structured interview, discrepancies among
raters remained a problem: when, during a trial on a
Fig. 2 Toxic and protective events in TBI over time
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neuroprotective agent, the results of interviews were
reviewed centrally, more than one-third of the scores were
discordant [51]. Alternative methods for reducing inter-
rater differences using the GOS were then proposed [52],
focusing on education and central monitoring.
Objective measurements of mental and physical func-
tion, as performed using a range of tools, may miss the
patient’s own perspective on QoL, while he/she is the
most qualified expert for evaluating the quality of his/
her own life.
This could be captured by instruments for assessing
the generic health status, such as the Medical Outcomes
Survey 36-Item Short Form Health Questionnaire (SF-
36) [53], or by tools specifically designed for TBI, such
as the Quality of Life after Brain Injury (QOLIBRI), a
37-item scale with six subscales covering areas of
wellbeing and functioning that are typically affected
by TBI, plus a total score which provides a summary
of QoL [54].
QoL is usually self-reported but self-reporting is not
suitable for the most severe cases, with aphasia or per-
sistent vegetative status.
Ideally a combination of instruments, such as the ex-
tended GOS and the QOLIBRI or other additional tools,
could document important domains that are often not
sufficiently investigated, such as interpersonal relation-
ships, social and leisure activities, self and the environ-
ment, etc. [55]. Using complicated and long tests,
however, may be cumbersome or unbearable for pa-
tients: when accurate testing was attempted in more
Fig. 3 Advanced diffusion imaging in a normal control subject (a–c) and a TBI patient (d–f). a, d Axial T2-weighted images at 0.7-mm isotropic
resolution. b, e Fractional anisotropy and c, f mean diffusivity from diffusion tensor imaging. Cc corpus callosum, Cg cingulum, CR corona radiata,
LV lateral ventricle. The color scheme indicates quantitative diffusion parameters (not direction of fibers). Processing included averaging of
two acquisitions with opposite phase encoding direction acquisitions and eddy current correction plus motion correction using the Human
Connectome Project pipeline which included FSL 5.0.6. (L. Holleran, JH Kim, and DL Brody, unpublished data)
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than 1000 patients enrolled in the Traumatic Coma Data
Bank, less than 100 completed the full test battery [56].
Outcome changes over time
The temporal profile of outcome was first established in
the first months following TBI, based on the observation
that a significant proportion of patients improve con-
tinuously during the first 6 months after injury, stabiliz-
ing thereafter. When 786 TBI patients were followed up
for 1 year, 35 % achieved a favorable outcome at
6 months and an additional 5 % reached this level at one
year [57]. The finding that the most significant improve-
ments, especially in the physical status, happen during
the first 6 months has been confirmed in more recent
series [58]. For this reason almost all major TBI trials in
the past 20 years have assessed outcome 6 months after
injury.
Evidence is accumulating, however, that outcomes
after TBI may change after greater periods of time after
trauma, in the direction of both further recovery and,
unfortunately, progressive worsening. Additionally, some
evidence suggests that TBI is a trigger of a persistent,
chronic disease, with late deterioration several years after
injury [19]. The evidence that about 25 % of TBI cases
show functional deterioration between 7 and 13 years
post-TBI indicates that, in some patients surviving the
acute injury, TBI may be the substrate for the induction
of neurodegenerative chronic processes.
Long-term consequences
Excess mortality
TBI patients have a higher mortality rate than controls
matched for age and sex. Behavioral problems, impulsiv-
ity, suicide, motor accidents, etc. are more common in
young survivors, while in cases older than 45 years med-
ical problems such as pneumonia, sepsis, and neurode-
generative diseases are associated with early deaths. In
an American study the risk of dying was 2.2 times more
than controls considering moderate to severe TBI who
received inpatient rehabilitation, with an average reduc-
tion of life expectancy of 6.6 years [59]. The data were
much worse for individuals who were unable to follow
commands on admission to rehabilitation: they were 6.9
times more likely to die, with an average life expectancy
reduction of 12.2 years.
Vegetative status and minimally conscious state
The vegetative state (or “unresponsive wakefulness
syndrome”) is a complex neurological condition in which
patients appear to be awake but show no sign of aware-
ness of themselves or their environment [60]. This con-
dition may be transient, preceding further recovery, or
persist. If repeated accurate assessments confirm unre-
sponsiveness 1 year after injury, a persistent vegetative
state is diagnosed [59]. A high rate of misdiagnosis is
reported because of the barriers to communication from
the patient and the environment, so that patients with
minimal, but present, responses (minimally conscious
state) are confused with cases without responsiveness.
These responses can be detected by complementing clin-
ical evaluation with electrophysiology [61] and sophisti-
cated imaging techniques [62].
Physical disabilities
Motor and sensory deficits may persist as a consequence
of specific traumatic damage to the underlying nervous
structures. In the most severe cases, additional damage
due to prolonged immobilization during hospital care,
such as peri-articular calcification, may worsen recovery.
Bladder and sphincter control may be impaired. All
these physical disabilities may cause significant handicap
and limit the return to a normal and productive life.
Dementia
TBI has been identified as a risk factor for dementia but
this topic is still debated. A large retrospective cohort
(more than 50,000 mild, moderate, and severe TBI cases)
identified 4361 (8.4 %) cases who developed dementia.
In a stratified adjusted analysis, moderate to severe TBI
was associated with increased risk of dementia across all
ages, whereas mild TBI appeared to be a more important
risk factor only in older cases (65 years or older) [63].
Endocrinopathies
Individual hormonal deficiencies after adult TBI are
greatly variable in different reported studies. Chronic
dysfunction of the pituitary axis is observed in approxi-
mately 35 % of individuals who sustain a moderate-to-
severe TBI. The most common deficiency is that of
growth hormone (GH), followed by gonadotropin, corti-
sol, and thyroid [64]. GH replacement provides clinically
relevant, long-term QoL benefits in TBI patients with
severe hypopituitarism [65]. When hormone deficits are
not recognized and managed appropriately, they may
profoundly affect both the results of the rehabilitative
efforts and the final outcome of the subjects.
Cognitive impairment
TBI causes deficits of attention, memory, information
processing speed, and executive functioning. High-level
cognitive functions depend on well functioning distrib-
uted brain networks and on finely regulated neurotrans-
mitter systems [8, 15], which may be disrupted by injury.
When a group of moderate to severe TBI cases was ex-
tensively studied through comprehensive neuropsycho-
logical screening, deficits in sustained attention, paired
associate learning, and reaction time have been clearly
shown [66].
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The relationship between TBI severity and neuro-
psychological deficits has been studied up to 10 years
after injury [67]. Fifty per cent of mild cases recovered
complete cognitive competency, while an additional
20 % required “some help”. On the other end of the
spectrum, only 30 % of the more severe cases fully re-
covered [68]. More encouraging data on mild injuries re-
covery are reported in a recent systematic review [5].
White matter damage in definite locations, as demon-
strated by advanced imaging techniques, seems to be
associated with specific disorders: for instance, lesions to
the fornices are correlated with associative learning and
memory deficits; frontal lobe lesions are strictly linked
with executive function impairment [15]. Grey matter
lesions (especially in the orbitofrontal and insular corti-
ces and in the caudate) seem associated with impulsivity;
impairment of decision making, with longer deliberation
times, also seems to be associated with a number of ana-
tomical lesions [8].
As already mentioned, TBI is increasingly affecting an
aging population in several countries; the neural loss
that accompanies normal ageing might combine or
interact with the brain damage caused by a TBI and
worsen patients’ cognitive and social abilities [69, 70].
Psychiatric disorders
Psychiatric disorders are common following TBI and
include depression, anxiety, and psychosis, as well as
other maladaptive behaviors and personality changes.
A recent meta-analysis shows that TBI increases the
incidence of psychiatric disorders, with depression
and bipolar disorders having higher odds ratios, 2.1
and 1.85, respectively. Psychiatric symptoms may be
temporary, limited to the first weeks after injury, or
persistent. They may limit participation in rehabilita-
tion and functional independence in the community.
Long-term psychiatric disorders are associated with
greater risk for substance abuse [71].
Seizures
The incidence of seizures after TBI is variable, depend-
ing on the mechanism, the location, and the extent of
brain damage and on appropriate treatment. Penetrating
injuries are very often the cause of seizures, which may
affect up to 50 % of patients. In closed TBI, the inci-
dence of late seizures is lower but it may vary between 9
and 42 % in untreated patients [72]. Other sources indi-
cate an incidence of 25–30 % after severe TBI and 5–
10 % after mild to moderate injury [73]. There is low-
quality evidence that early treatment with antiepileptic
drugs reduces the risk of early post-traumatic seizures
and no evidence to support a reduction in the risk of
late seizures [74].
Employment
The combination of physical and functional deficits dis-
cussed translates into a high rate of un-employment in
survivors of TBI. Patients recovering from severe TBI
are sometimes offered a sheltered working environment,
while return to previous work positions is rare. In a USA
series 73 % of cases with mild initial injury return to pre-
vious jobs; this proportion falls to 49 % for severe pa-
tients [68]. Even patients of working age with apparently
favorable outcomes have difficulties in restarting their
jobs: in a group studied in Norway 10 years after injury,
the rate of employment was 58 % [67].
Sexuality
Brain injury can directly and indirectly affect important
aspects related to sexuality and sexual function. Physical
(for instance pituitary dysfunction) and psychological
components (such as depression) may both result in im-
paired sexual activities. When sexual function has been
studied 1 year after TBI with self-reports and structured
interviews, significant disturbances were detected [75];
29 % of participants reported dissatisfaction with sexual
functioning, with a greater percentage of men reporting
dissatisfaction.
Sexual issues and sexual needs are rarely discussed and
managed during the rehabilitation phase after TBI [76].
Impairment of social and leisure activities
The combination of physical, cognitive, and emotional
impairments creates a major obstacle for re-entry into
the community. Decreased social contact, depression,
and loneliness combined with reduced financial re-
sources, unemployment, and physical disabilities may se-
verely disrupt previous social networks and make social
and leisure activities impossible [77].
When several parameters (neuropsychological func-
tioning, emotional status, functional status, employment,
and perceived QoL) were assessed in 201 patients with
moderate or severe TBI up to 3–5 years after injury, re-
covery to pre-injury levels ranged from 65 % of cases
with regard to personal care to approximately 40 % with
regard to cognitive competency, major activities, and
leisure and recreation [68]. These figures were related to
initial TBI severity.
Other series measuring QoL and comparing it with
matched comparators confirm these findings: TBI cases
experienced worse general health, elevated probabilities
of depression, social isolation, and worse labor-force par-
ticipation rates. The most affected areas were social
function, emotions, and mental health [78]. Patients typ-
ically report “somewhat lower life satisfaction and affect”
as a consequence of TBI [79]. QoL is consistently worse
in older patients, as documented after the evacuation of
subdural hematomas [80].
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What can be done to minimize long-term consequences
and improve outcome
TBI consequences can be attenuated with appropriate
and prolonged care. When professional help is linked
with family assistance, the results may further improve.
This, however, requires an organized system of care,
financial resources, and a solid supportive network of
“next of kin”.
For these reasons people with very limited financial re-
sources and/or no familiar and social support are ex-
posed to the worse TBI consequences. A typical
demonstration of this concept has been documented in
a cohort of homeless TBI patients in Scotland. The
homeless have a 5.4 times increased risk of TBI com-
pared with the normal population. After discharge back
to their condition of homelessness, they had double the
mortality rate compared with homeless cases not hospi-
talized [81].
A key issue in TBI care is the temporal progression of
tissue damage, with long-lasting pathological cascades.
Angiogenesis, neurogenesis, and brain plasticity, spon-
taneous regenerative mechanisms induced after acute
brain injury, are too weak to counteract damage progres-
sion. If those mechanisms could be modulated and
strengthened, new therapeutic possibilities could be
explored.
Conclusions
Traditionally seen as a sudden, brutal event with short-
term consequences, TBI may cause persistent, some-
times life-long, consequences.
A huge amount of work has been invested in improv-
ing early TBI care, from rescue to emergency surgical in-
terventions, prevention of secondary insults, acute
treatment of intracranial hypertension in intensive care,
etc. Data bases with ten thousands of patients have been
assembled to better define diagnosis, management, and
prognosis in the acute phase. In contrast, fewer data,
usually on a very limited numbers of cases, are available
on long-term outcomes. This is striking, because bring-
ing patients with head injuries back to an enjoyable life
should be the ultimate goal of any treatment.
Important long-term consequences have been identified
not only after severe TBI but also in a relevant proportion
of cases previously classified as moderate or mild.
Better understanding of the damage mechanisms and
new approaches to neuroprotection-restoration may
offer better outcomes for millions of survivors of TBI.
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